See up to 3 months of URGN. The 7-day demo opens the 1M and 3M ranges and puts URGN on your watchlist.
Start 7-day demoLatest URGN insider trades
About UroGen Pharma Ltd. (URGN)
UroGen Pharma Ltd. is an SEC registrant, filing under CIK 0001668243, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
URGN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 4 | 65,269 | $3.04M |
| Option exercise | 8 | 22,968 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
URGN insider transactions (Form 4)
2242 Form 4 filings on record, the earliest from Oct 9, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jason Drew Smith - Officer | Option exercise | Ordinary Shares | 3,333 | - | - | |
| Jason Drew Smith - Officer | Open-market sale | Ordinary Shares | 1,520 | $19.11 | $29K | |
| Jason Drew Smith - Officer | Option exercise | Restricted Stock Units | 3,333 | $0.00 | - | |
| Daniel George Wildman - Director | Grant or award | Stock Option (right ot buy) | 10,000 | $0.00 | - | |
| Daniel George Wildman - Director | Grant or award | Restricted Stock Unit | 8,000 | $0.00 | - | |
| James A. Robinson Jr. - Director | Grant or award | Stock Option (right ot buy) | 10,000 | $0.00 | - | |
| James A. Robinson Jr. - Director | Grant or award | Restricted Stock Unit | 8,000 | $0.00 | - | |
| Stuart Holden - Director | Grant or award | Stock Option (right ot buy) | 10,000 | $0.00 | - | |
| Stuart Holden - Director | Grant or award | Restricted Stock Unit | 8,000 | $0.00 | - | |
| Leana Wen - Director | Grant or award | Stock Option (right ot buy) | 10,000 | $0.00 | - | |
| Leana Wen - Director | Grant or award | Restricted Stock Unit | 8,000 | $0.00 | - | |
 Arie Belldegrun - Director | Grant or award | Stock Option (right ot buy) | 20,000 | $0.00 | - | |
| Cynthia M. Butitta - Director | Grant or award | Stock Option (right ot buy) | 10,000 | $0.00 | - | |
| Cynthia M. Butitta - Director | Grant or award | Restricted Stock Unit | 8,000 | $0.00 | - | |
| Mark Schoenberg - Officer | Open-market sale | Ordinary Shares | 10,000 | $17.69 | $177K | |
| Elizabeth A. Barrett - Officer | Grant or award | Performance Stock Units | 87,615 | $0.00 | - | |
| Jason Drew Smith - Officer | Option exercise | Ordinary Shares | 16,500 | - | - | |
| Jason Drew Smith - Officer | Open-market sale | Ordinary Shares | 7,522 | $19.14 | $144K | |
| Mark Schoenberg - Officer | Option exercise | Ordinary Shares | 10,000 | - | - | |
| Mark Schoenberg - Officer | Open-market sale | Ordinary Shares | 5,149 | $19.14 | $99K | |
| Chris Degnan - Officer | Grant or award | Restricted Stock Units | 13,450 | $0.00 | - | |
| Chris Degnan - Officer | Grant or award | Employee Stock Option (right to buy) | 74,142 | $0.00 | - |
Recent URGN Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Christopher Degnan | Officer | 2,202 | $90K | View on EDGAR | |
| Mark Schoenberg | Officer | 871 |
URGN insider trading FAQ
What is the latest insider trade for URGN?
UroGen Pharma Ltd. (URGN) had 5 insider filings in the last 90 days, with the most recent on 2026-10-09. The full record for URGN runs to 42 Form 4 filings, the earliest from 2024-10-09. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying URGN stock?
No insider purchases of URGN were filed in the last 90 days.
How many insiders are selling URGN stock?
4 insider sales of URGN were filed in the last 90 days, totaling $3.04M.
Where can I see URGN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects URGN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Chris Degnan view on EDGAR
- - Mark Schoenberg view on EDGAR
- - Jason Drew Smith view on EDGAR
- - James A. Robinson Jr. view on EDGAR
- - Mark Schoenberg view on EDGAR
- - Mark Schoenberg view on EDGAR
- - Mark Schoenberg view on EDGAR
- - Daniel George Wildman view on EDGAR
- - James A. Robinson Jr. view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where URGN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow URGN with a 7-day demo
- URGN on your watchlist
- Every URGN Form 4 filing on record
- Up to 3 months of URGN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
